{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T09:20:01Z","timestamp":1791537601723,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["P2-0249"],"award-info":[{"award-number":["P2-0249"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["I0-0022"],"award-info":[{"award-number":["I0-0022"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["BI-HR\/16-17-039"],"award-info":[{"award-number":["BI-HR\/16-17-039"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioMed Eng OnLine"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The effectiveness of electrochemotherapy of tumors (ECT) and of irreversible electroporation ablation (IRE) depends on different mechanisms and delivery protocols. Both therapies exploit the phenomenon of electroporation of the cell membrane achieved by the exposure of the cells to a series of high-voltage electric pulses. Electroporation can be fine-tuned to be either reversible or irreversible, causing the cells to either survive the exposure (in ECT) or not (in IRE), respectively. For treatment of tissues located close to the heart (e.g., in the liver), the safety of electroporation-based therapies is ensured by synchronizing the electric pulses with the electrocardiogram. However, the use of ECT and IRE remains contraindicated for patients with implanted cardiac pacemakers if the treated tissues are located close to the heart or the pacemaker. In this study, two questions are addressed: can the electroporation pulses interfere with the pacemaker; and, can the metallic housing of the pacemaker modify the distribution of electric field in the tissue sufficiently to affect the effectiveness and safety of the therapy?<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The electroporation pulses induced significant changes in the pacemaker ventricular pacing pulse only for the electroporation pulses delivered during the pacing pulse itself. No residual effects were observed on the pacing pulses following the electroporation pulses for all tested experimental conditions. The results of numerical modeling indicate that the presence of metal-encased pacemaker in immediate vicinity of the treatment zone should not impair the intended effectiveness of ECT or IRE even when the casing is in direct contact with one of the active electrodes. Nevertheless, the contact between the casing and the active electrode should be avoided due to significant tissue heating at the site of the other active electrode for the IRE protocol and may cause the pulse generator to fail to deliver the pulses due to excessive current draw.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The observed effects of electroporation pulses delivered in close vicinity of the pacemaker or its electrodes do not indicate adverse consequences for either the function of the pacemaker or the treatment outcome. These findings should contribute to making electroporation-based treatments accessible also to patients with implanted cardiac pacemakers.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12938-020-00827-7","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T12:04:47Z","timestamp":1605528287000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Investigation of safety for electrochemotherapy and irreversible electroporation ablation therapies in patients with cardiac pacemakers"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9218-1755","authenticated-orcid":false,"given":"Tomaz","family":"Jarm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadej","family":"Krmac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratko","family":"Magjarevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bor","family":"Kos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Cindric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damijan","family":"Miklavcic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,16]]},"reference":[{"key":"827_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1146\/annurev-biophys-052118-115451","volume":"48","author":"T Kotnik","year":"2019","unstructured":"Kotnik T, Rems L, Tarek M, Miklav\u010di\u010d D. Membrane electroporation and electropermeabilization: mechanisms and models. Annu Rev Biophys. 2019;48:63\u201391.","journal-title":"Annu Rev Biophys"},{"key":"827_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev-bioeng-071813-104622","volume":"16","author":"ML Yarmush","year":"2014","unstructured":"Yarmush ML, Golberg A, Ser\u0161a G, Kotnik T, Miklav\u010di\u010d D. Electroporation-based technologies for medicine: principles, applications, and challenges. Annu Rev Biomed Eng. 2014;16:295\u2013320.","journal-title":"Annu Rev Biomed Eng"},{"key":"827_CR3","volume-title":"Handbook of electroporation","year":"2017","unstructured":"Miklavcic D, editor. Handbook of electroporation. Berlin: Springer International Publishing; 2017."},{"issue":"11","key":"827_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejcsup.2006.08.002","volume":"4","author":"M Marty","year":"2006","unstructured":"Marty M, Ser\u0161a G, Garbay JR, Gehl J, Collins CG, Snoj M, et al. Electrochemotherapy\u2014an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer Suppl. 2006;4(11):3\u201313.","journal-title":"Eur J Cancer Suppl"},{"issue":"11","key":"827_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejcsup.2006.08.005","volume":"4","author":"LM Mir","year":"2006","unstructured":"Mir LM. Bases and rationale of the electrochemotherapy. Eur J Cancer Suppl. 2006;4(11):38\u201344.","journal-title":"Eur J Cancer Suppl"},{"issue":"1","key":"827_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1475-925X-13-29","volume":"13","author":"D Miklav\u010di\u010d","year":"2014","unstructured":"Miklav\u010di\u010d D, Mali B, Kos B, Heller R, Ser\u0161a G. Electrochemotherapy: from the drawing board into medical practice. Biomed Eng Online. 2014;13(1):29.","journal-title":"Biomed Eng Online"},{"issue":"2","key":"827_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0302-4598(96)05194-X","volume":"43","author":"G Ser\u0161a","year":"1997","unstructured":"Ser\u0161a G, Miklav\u010di\u010d D, \u010cema\u017ear M, Belehradek J, Jarm T, Mir LM. Electrochemotherapy with CDDP on LPB sarcoma: comparison of the anti-tumor effectiveness in immunocompetent and immunodeficient mice. Bioelectrochem Bioenerg. 1997;43(2):279\u201383.","journal-title":"Bioelectrochem Bioenerg"},{"issue":"2","key":"827_CR8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejso.2018.11.023","volume":"45","author":"LG Campana","year":"2019","unstructured":"Campana LG, Edhemovic I, Soden D, Perrone AM, Scarpa M, Campanacci L, et al. Electrochemotherapy\u2014emerging applications technical advances, new indications, combined approaches, and multi-institutional collaboration. Eur J Surg Oncol. 2019;45(2):92\u2013102.","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"827_CR9","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.ejso.2019.11.509","volume":"46","author":"AJP Clover","year":"2020","unstructured":"Clover AJP, Salwa SP, Bourke MG, McKiernan J, Forde PF, O\u2019Sullivan ST, et al. Electrochemotherapy for the treatment of primary basal cell carcinoma; A randomised control trial comparing electrochemotherapy and surgery with five year follow up. Eur J Surg Oncol. 2020;46(5):847\u201354.","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"827_CR10","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1080\/0284186X.2018.1454602","volume":"57","author":"J Gehl","year":"2018","unstructured":"Gehl J, Sersa G, Matthiessen LW, Muir T, Soden D, Occhini A, et al. Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncol. 2018;57(7):874\u201382.","journal-title":"Acta Oncol"},{"issue":"2","key":"827_CR11","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1148\/radiol.2020192190","volume":"295","author":"B Geboers","year":"2020","unstructured":"Geboers B, Scheffer HJ, Graybill PM, Ruarus AH, Nieuwenhuizen S, Puijk RS, et al. High-voltage electrical pulses in oncology: irreversible electroporation, electrochemotherapy, gene electrotransfer, electrofusion, and electroimmunotherapy. Radiology. 2020;295(2):254\u201372.","journal-title":"Radiology"},{"key":"827_CR12","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.2147\/OTT.S88086","volume":"9","author":"PG Wagstaff","year":"2016","unstructured":"Wagstaff PG, Buijs M, van den Bos W, de Bruin DM, Zondervan PJ, de la Rosette JJ, et al. Irreversible electroporation: state of the art. OncoTargets Ther. 2016;9:2437\u201346.","journal-title":"OncoTargets Ther"},{"issue":"4","key":"827_CR13","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1089\/bioe.2019.0029","volume":"1","author":"KN Aycock","year":"2019","unstructured":"Aycock KN, Davalos RV. Irreversible electroporation: background, theory, and review of recent developments in clinical oncology. Bioelectricity. 2019;1(4):214\u201334.","journal-title":"Bioelectricity"},{"issue":"8","key":"827_CR14","doi-asserted-by":"publisher","first-page":"e103083","DOI":"10.1371\/journal.pone.0103083","volume":"9","author":"PA Garcia","year":"2014","unstructured":"Garcia PA, Davalos RV, Miklavcic D. A numerical investigation of the electric and thermal cell kill distributions in electroporation-based therapies in tissue. PLoS ONE. 2014;9(8):e103083.","journal-title":"PLoS ONE"},{"issue":"1","key":"827_CR15","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1080\/02656736.2020.1753828","volume":"37","author":"P Agnass","year":"2020","unstructured":"Agnass P, van Veldhuisen E, van Gemert MJC, van der Geld CWM, van Lienden KP, van Gulik TM, et al. Mathematical modeling of the thermal effects of irreversible electroporation for in vitro, in vivo, and clinical use: a systematic review. Int J Hyperth. 2020;37(1):486\u2013505.","journal-title":"Int J Hyperth"},{"issue":"7","key":"827_CR16","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.jvir.2014.01.028","volume":"25","author":"HJ Scheffer","year":"2014","unstructured":"Scheffer HJ, Nielsen K, de Jong MC, van Tilborg AAJM, Vieveen JM, Bouwman ARA, et al. Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy. J Vasc Interv Radiol JVIR. 2014;25(7):997\u20131011 (quiz 1011).","journal-title":"J Vasc Interv Radiol JVIR"},{"issue":"1","key":"827_CR17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.2478\/raon-2019-0011","volume":"53","author":"N Verloh","year":"2019","unstructured":"Verloh N, Jensch I, L\u00fcrken L, Haimerl M, Dollinger M, Renner P, et al. Similar complication rates for irreversible electroporation and thermal ablation in patients with hepatocellular tumors. Radiol Oncol. 2019;53(1):116\u201322.","journal-title":"Radiol Oncol"},{"issue":"1","key":"827_CR18","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1148\/radiol.2019191109","volume":"294","author":"AH Ruarus","year":"2019","unstructured":"Ruarus AH, Vroomen LGPH, Geboers B, van Veldhuisen E, Puijk RS, Nieuwenhuizen S, et al. Percutaneous irreversible electroporation in locally advanced and recurrent pancreatic cancer (PANFIRE-2): a multicenter, prospective, single-arm phase II study. Radiology. 2019;294(1):212\u201320.","journal-title":"Radiology"},{"issue":"2","key":"827_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/17434440.2018.1425612","volume":"15","author":"EI Cohen","year":"2018","unstructured":"Cohen EI, Field D, Lynskey GE, Kim AY. Technology of irreversible electroporation and review of its clinical data on liver cancers. Expert Rev Med Devices. 2018;15(2):99\u2013106.","journal-title":"Expert Rev Med Devices"},{"issue":"3","key":"827_CR20","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1515\/raon-2015-0031","volume":"49","author":"B Kos","year":"2015","unstructured":"Kos B, Voigt P, Miklavcic D, Moche M. Careful treatment planning enables safe ablation of liver tumors adjacent to major blood vessels by percutaneous irreversible electroporation (IRE). Radiol Oncol. 2015;49(3):234\u201341.","journal-title":"Radiol Oncol"},{"issue":"Suppl 3","key":"827_CR21","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/1475-925X-14-S3-S2","volume":"14","author":"A Gro\u0161elj","year":"2015","unstructured":"Gro\u0161elj A, Kos B, \u010cema\u017ear M, Urban\u010di\u010d J, Kragelj G, Bo\u0161njak M, et al. Coupling treatment planning with navigation system: a new technological approach in treatment of head and neck tumors by electrochemotherapy. Biomed Eng Online. 2015;14(Suppl 3):S2.","journal-title":"Biomed Eng Online"},{"issue":"3","key":"827_CR22","doi-asserted-by":"publisher","first-page":"I1","DOI":"10.1186\/1475-925X-14-S3-I1","volume":"14","author":"D Miklav\u010di\u010d","year":"2015","unstructured":"Miklav\u010di\u010d D, Davalos RV. Electrochemotherapy (ECT) and irreversible electroporation (IRE)-advanced techniques for treating deep-seated tumors based on electroporation. Biomed Eng OnLine. 2015;14(3):I1.","journal-title":"Biomed Eng OnLine"},{"issue":"4","key":"827_CR23","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s00270-019-02164-2","volume":"42","author":"N Kalra","year":"2019","unstructured":"Kalra N, Gupta P, Gorsi U, Bhujade H, Chaluvashetty SB, Duseja A, et al. Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience. Cardiovasc Intervent Radiol. 2019;42(4):584\u201390.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"827_CR24","unstructured":"Frequently Asked Questions | IGEA. https:\/\/www.igea.it\/en\/oncology\/information-clinicians\/frequently-asked-questions. Accessed 20 Aug 2019."},{"key":"827_CR25","unstructured":"Risk Information. AngioDynamics. https:\/\/www.angiodynamics.com\/about-us\/risk-information\/. Accessed 20 Aug 2019."},{"issue":"2","key":"827_CR26","doi-asserted-by":"publisher","first-page":"e0148457","DOI":"10.1371\/journal.pone.0148457","volume":"11","author":"HJ Scheffer","year":"2016","unstructured":"Scheffer HJ, Vogel JA, van den Bos W, Neal RE, van Lienden KP, Besselink MGH, et al. The influence of a metal stent on the distribution of thermal energy during irreversible electroporation. PLoS ONE. 2016;11(2):e0148457.","journal-title":"PLoS ONE"},{"issue":"7","key":"827_CR27","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/jso.24404","volume":"114","author":"RCG Martin","year":"2016","unstructured":"Martin RCG, Durham AN, Besselink MG, Iannitti D, Weiss MJ, Wolfgang CL, et al. Irreversible electroporation in locally advanced pancreatic cancer: a call for standardization of energy delivery. J Surg Oncol. 2016;114(7):865\u201371.","journal-title":"J Surg Oncol"},{"key":"827_CR28","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s00270-019-02300-y","volume":"43","author":"FH Cornelis","year":"2019","unstructured":"Cornelis FH, Cindri\u010d H, Kos B, Fujimori M, Petre EN, Miklav\u010di\u010d D, et al. Peri-tumoral metallic implants reduce the efficacy of irreversible electroporation for the ablation of colorectal liver metastases. Cardiovasc Intervent Radiol. 2019;43:84\u201393.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"9","key":"827_CR29","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/bjs.9536","volume":"101","author":"EM Dunki-Jacobs","year":"2014","unstructured":"Dunki-Jacobs EM, Philips P, Martin RCG. Evaluation of thermal injury to liver, pancreas and kidney during irreversible electroporation in an in vivo experimental model. Br J Surg. 2014;101(9):1113\u201321.","journal-title":"Br J Surg"},{"issue":"2","key":"827_CR30","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1148\/radiol.12120609","volume":"266","author":"M Faroja","year":"2013","unstructured":"Faroja M, Ahmed M, Appelbaum L, Ben-David E, Moussa M, Sosna J, et al. Irreversible electroporation ablation: is all the damage nonthermal? Radiology. 2013;266(2):462\u201370.","journal-title":"Radiology"},{"issue":"1","key":"827_CR31","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1038\/s41598-019-40395-y","volume":"9","author":"J Zmuc","year":"2019","unstructured":"Zmuc J, Gasljevic G, Sersa G, Edhemovic I, Boc N, Seliskar A, et al. Large liver blood vessels and bile ducts are not damaged by electrochemotherapy with bleomycin in pigs. Sci Rep. 2019;9(1):3649.","journal-title":"Sci Rep"},{"key":"827_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-6907-0","volume-title":"Implantable cardiac devices technology","author":"D Korpas","year":"2013","unstructured":"Korpas D. Implantable cardiac devices technology. Berlin: Springer; 2013."},{"issue":"4","key":"827_CR33","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1177\/153303460700600408","volume":"6","author":"C Bertacchini","year":"2007","unstructured":"Bertacchini C, Margotti PM, Bergamini E, Lodi A, Ronchetti M, Cadossi R. Design of an irreversible electroporation system for clinical use. Technol Cancer Res Treat. 2007;6(4):313\u201320.","journal-title":"Technol Cancer Res Treat"},{"key":"827_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1475-925X-10-34","volume":"10","author":"PA Garcia","year":"2011","unstructured":"Garcia PA, Rossmeisl JH, Neal RE, Ellis TL, Davalos RV. A parametric study delineating irreversible electroporation from thermal damage based on a minimally invasive intracranial procedure. Biomed Eng OnLine. 2011;10:34.","journal-title":"Biomed Eng OnLine"},{"key":"827_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1475-925X-12-16","volume":"12","author":"S Corovic","year":"2013","unstructured":"Corovic S, Lackovic I, Sustaric P, Sustar T, Rodic T, Miklavcic D. Modeling of electric field distribution in tissues during electroporation. Biomed Eng Online. 2013;12:16.","journal-title":"Biomed Eng Online"},{"issue":"5","key":"827_CR36","doi-asserted-by":"publisher","first-page":"055016","DOI":"10.1088\/1361-6560\/ab00c4","volume":"64","author":"O Gallinato","year":"2019","unstructured":"Gallinato O, de Senneville BD, Seror O, Poignard C. Numerical workflow of irreversible electroporation for deep-seated tumor. Phys Med Biol. 2019;64(5):055016.","journal-title":"Phys Med Biol"},{"issue":"S1","key":"827_CR37","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.3233\/JAE-209118","volume":"63","author":"B L\u00f3pez-Alonso","year":"2020","unstructured":"L\u00f3pez-Alonso B, Sarnago H, Burd\u00edo JM, Luc\u00eda O. Electro-thermal modeling of irreversible electroporation and validation method of electric field distribution. Int J Appl Electromagn Mech. 2020;63(S1):S41-50.","journal-title":"Int J Appl Electromagn Mech"},{"key":"827_CR38","doi-asserted-by":"crossref","unstructured":"Jarm T, Krmac T, Miklavcic D, Magjarevic R. Cardiac Pacemaker exposed to electroporation pulses\u2014an ex vivo study. In: Henriques J, Neves N, de Carvalho P, editors. XV mediterranean conference on medical and biological engineering and computing\u2014MEDICON 2019 (IFMBE proceedings). Cham: Springer International Publishing; 2020. p. 439\u201346.","DOI":"10.1007\/978-3-030-31635-8_53"},{"issue":"1","key":"827_CR39","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00232-010-9274-1","volume":"236","author":"B Kos","year":"2010","unstructured":"Kos B, \u017dupani\u010d A, Kotnik T, Snoj M, Ser\u0161a G, Miklav\u010di\u010d D. Robustness of treatment planning for electrochemotherapy of deep-seated tumors. J Membr Biol. 2010;236(1):147\u201353.","journal-title":"J Membr Biol"},{"key":"827_CR40","first-page":"360","volume-title":"Physical properties of tissue: a comprehensive reference book","author":"FA Duck","year":"2012","unstructured":"Duck FA. Physical properties of tissue: a comprehensive reference book. York: Institute of Physics and Engineering in Medicine; 2012. p. 360."},{"key":"827_CR41","unstructured":"DATABASE\u202f\u00bb IT\u2019IS Foundation. https:\/\/itis.swiss\/virtual-population\/tissue-properties\/database\/. Accessed 18 Feb 2020."},{"issue":"5","key":"827_CR42","doi-asserted-by":"publisher","first-page":"e0125591","DOI":"10.1371\/journal.pone.0125591","volume":"10","author":"M Mar\u010dan","year":"2015","unstructured":"Mar\u010dan M, Kos B, Miklav\u010di\u010d D. Effect of blood vessel segmentation on the outcome of electroporation-based treatments of liver tumors. PLoS ONE. 2015;10(5):e0125591.","journal-title":"PLoS ONE"},{"issue":"5","key":"827_CR43","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1109\/TDEI.2009.5293947","volume":"16","author":"I Lackovi\u0107","year":"2009","unstructured":"Lackovi\u0107 I, Magjarevi\u0107 R, Miklav\u010di\u010d D. Three-dimensional finite-element analysis of joule heating in electrochemotherapy and in vivo gene electrotransfer. IEEE Trans Dielectr Electr Insul. 2009;16(5):1338\u201347.","journal-title":"IEEE Trans Dielectr Electr Insul"}],"container-title":["BioMedical Engineering OnLine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12938-020-00827-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12938-020-00827-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12938-020-00827-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T03:03:04Z","timestamp":1605582184000},"score":1,"resource":{"primary":{"URL":"https:\/\/biomedical-engineering-online.biomedcentral.com\/articles\/10.1186\/s12938-020-00827-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,16]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["827"],"URL":"https:\/\/doi.org\/10.1186\/s12938-020-00827-7","relation":{},"ISSN":["1475-925X"],"issn-type":[{"value":"1475-925X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,16]]},"assertion":[{"value":"23 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DM was in the past a consultant receiving consultancy fees and grants from IGEA S.p.A (Carpi, Modena, Italy) and has currently the same status with Medtronic (Minneapolis, MN, USA). BK is currently a consultant for Medtronic (Minneapolis, MN, USA). Apart from this, the authors declare that they have no other competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}